Obesity associated with type 2 diabetes mellitus is linked to decreased PC1/3 mRNA expression in the Jejunum

Francieli Rohden1, Cintia S Costa, Thais O Hammes

  • 1Departamento de Bioquímica, ICBS, UFRGS, Rua Ramiro Barcelos 2600 - anexo, CEP 90.035-003, Porto Alegre, RS, Brazil.

Obesity Surgery
|May 17, 2014
PubMed
Abstract

Insights

Obese patients with type 2 diabetes have impaired prohormone convertase 1/3 (PC1/3) mRNA expression in the jejunum. Bariatric surgery may improve glucose levels by activating this system.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Gastroenterology

Background:

  • Bariatric surgery is a highly effective treatment for obesity and type 2 diabetes.
  • Incretin hormones play a crucial role in glucose regulation.
  • Understanding the molecular basis of incretin secretion is vital for managing obesity and diabetes.

Purpose of the Study:

  • To investigate messenger RNA (mRNA) gene expression of key incretin-related molecules in the jejunum of obese patients with and without type 2 diabetes.
  • To explore the molecular underpinnings of incretin secretion in the context of bariatric surgery.

Main Methods:

  • Jejunal mucosa samples were collected from non-diabetic (NDM2) and type 2 diabetic (T2DM) obese patients.
  • Messenger RNA (mRNA) expression levels of proglucagon, GIP, PC1/3, and DPP-IV were analyzed using RT-qPCR.
  • Immuno content of GLP-1 and GIP was quantified via fluorescence microscopy.

Main Results:

  • Type 2 diabetes patients exhibited significantly decreased prohormone convertase 1/3 (PC1/3) mRNA expression in the jejunum.
  • Proglucagon, GIP, and DPP-IV mRNA expression levels were not significantly different between NDM2 and T2DM groups.
  • Glucagon-like peptide-1 and GIP immuno content decreased in T2DM jejunum, but high glucose stimulated these levels.

Conclusions:

  • Reduced PC1/3 mRNA expression in the jejunum may impair the bioactivation of pro-GIP and proglucagon in obese patients with T2DM.
  • Bariatric surgery could potentially enhance incretin secretion and improve glucose control in these patients by activating this system.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
15
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
27
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.3K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K